We have identified four particular areas of expertise, shown in the diagram below. As at 31 January 2016, the value of the top 10 investments in our portfolio stood at £232.6 million while our total portfolio was valued at £355.1 million.
A clinical-stage specialty biopharmaceutical company developing a range of novel immunotherapies
Using Xenon to prevent neuronal damage
Internet of Things solutions provider specialising in fully integrated business solutions around connected product intelligence.